Accredit equity Other April 18, 2024 Many of us may be familiar with the endless Commission on Cancer (CoC) accreditation standards, and this editorial asks: why…
The baby-sitters club Other March 8, 2024 In a move that yesterday left many a solo-practitioner in the rad onc world stunned, ASTRO released a letter to…
Putting the mouth where the money is Other October 30, 2023 A Medicare claims analysis identified four no- or low-value oncology interventions: (1) denosumab for castration sensitive prostate cancer, (2) a…
Expansive results Other July 6, 2023 This comprehensive review of the impact of Medicaid expansions ushered in by the Affordable Care Act indicates an associated increase…